APA (7th ed.) Citation

van der Weyden, L., Velasco-Herrera, M. D. C., Cheema, S., Wong, K., Boccacino, J. M., Vermes, I., . . . Segarra-Mondejar, M. (2025). Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategy. British Journal of Dermatology, 192(3), 551. https://doi.org/10.1093/bjd/ljae432

Chicago Style (17th ed.) Citation

van der Weyden, Louise, et al. "Exploration of the Mutational Landscape of Cutaneous Leiomyoma Confirms FH as a Driver Gene and Identifies Targeting Purine Metabolism as a Potential Therapeutic Strategy." British Journal of Dermatology 192, no. 3 (2025): 551. https://doi.org/10.1093/bjd/ljae432.

MLA (9th ed.) Citation

van der Weyden, Louise, et al. "Exploration of the Mutational Landscape of Cutaneous Leiomyoma Confirms FH as a Driver Gene and Identifies Targeting Purine Metabolism as a Potential Therapeutic Strategy." British Journal of Dermatology, vol. 192, no. 3, 2025, p. 551, https://doi.org/10.1093/bjd/ljae432.